Sort
48,018 grants matching “immunotherapy”
Training Grant in Molecular Imaging Research
$530,960Ralph Weissleder · Massachusetts General Hospital · T32 · FY2019 · CA
IDENTIFYING AND VALIDATING ONCOGENE-INDUCED MECHANISMS OF IMMUNOSUPPRESSION DOWNSTREAM OF THE ESRP1/FGFR2/KRAS AXIS TO IMPROVE IMMUNOTHERAPY
$530,941Queensland University Of Technology · · FY2022 · Defense Health Agency
Tissue engineering tools for monitoring the cellular and molecular response to therapy
$530,927Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
ENHANCING IMMUNOTHERAPY FOR TRIPLE-NEGATIVE AND HER2+ BREAST CANCER USING EPCAM APTAMER-SIRNA-MEDIATED GENE KNOCKDOWN.
$530,899Children'S Hospital Corporation, The · · FY2019 · Department of the Army
CLEC9A TARGETING ANTIBODIES AS A NEW IMMUNOTHERAPY FOR PROSTATE CANCER
$530,862The University Of Queensland · · FY2015 · Department of Defense
Human Subjects Core
$530,861Daniel L. Hamilos · Massachusetts General Hospital · U19 · FY2012 · AI
Project 1: Innate immune responses triggered by Listeria monocytogenes
$530,768Daniel A Portnoy · University Of California Berkeley · P01 · FY2020 · AI
Integrated Discovery Pipeline for Tumor Neoantigens
$530,736Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2019 · CA
Data Analysis Unit
$530,623Aviv Regev · Dana-Farber Cancer Inst · U2C · FY2018 · CA
Targeting the gut microbiome to inhibit melanoma lymph node metastases
$530,612Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Data Analysis Unit
$530,539Gad A Getz · Dana-Farber Cancer Inst · U2C · FY2020 · CA
Data Analysis Unit
$530,539Aviv Regev · Dana-Farber Cancer Inst · U2C · FY2019 · CA
Data Analysis Unit
$530,539Gad A Getz · Dana-Farber Cancer Inst · U2C · FY2022 · CA
Project 2: Radiation-Induced Lymphopenia: Understanding, Predictive Modeling and Developing Photon and Proton-Based Mitigation Strategies.
$530,451Steven Hsesheng Lin · Massachusetts General Hospital · P01 · FY2024 · CA
DISARMing the immunological barriers to regeneration in mammals
$530,451James W Godwin · Jackson Laboratory · R01 · FY2024 · HD
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$530,360Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2024 · CA
Translation of commensal bacteria mechanism for immunotherapy
$530,298Howard C Hang · Rockefeller University · R01 · FY2020 · CA
Tissue Resident memory T cell responses to cancer
$530,226Mary J Turk · Dartmouth College · R01 · FY2018 · CA
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$530,090Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2019 · CA
Structural Basis of Murine Diabetes
$530,024Luc Teyton · Scripps Research Institute, The · R01 · FY2008 · DK
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
$530,015Kevin C Barry · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$529,989Lawrence Fong · University Of California, San Francisco · P50 · FY2025 · CA
Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F6
$529,984Laura A Solt · Scripps Florida · R01 · FY2019 · CA
Engineering of pan-neutralizing anti-HIV envelope antibodies
$529,941Mohammad Mohseni Sajadi · University Of Maryland Baltimore · R01 · FY2022 · AI
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$529,878Nikhil Joshi · Yale University · R01 · FY2024 · CA